ES2051675T1 - Uso de ciertos herbicidas en el tratamiento del cancer y produccion de protoporfirina ix. - Google Patents

Uso de ciertos herbicidas en el tratamiento del cancer y produccion de protoporfirina ix.

Info

Publication number
ES2051675T1
ES2051675T1 ES90901350T ES90901350T ES2051675T1 ES 2051675 T1 ES2051675 T1 ES 2051675T1 ES 90901350 T ES90901350 T ES 90901350T ES 90901350 T ES90901350 T ES 90901350T ES 2051675 T1 ES2051675 T1 ES 2051675T1
Authority
ES
Spain
Prior art keywords
protoporphyrine
cells
treatment
production
protoporphyrinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES90901350T
Other languages
English (en)
Other versions
ES2051675T3 (es
Inventor
Blaik Phillip Halling
Debra Ann Witkowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
FMC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FMC Corp filed Critical FMC Corp
Publication of ES2051675T1 publication Critical patent/ES2051675T1/es
Application granted granted Critical
Publication of ES2051675T3 publication Critical patent/ES2051675T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE EXPONE UN METODO Y UN COMPUESTO FARMACEUTICO PARA ACABAR CON LAS CELULAS TUMOROSAS EN LOS MAMIFEROS AL SOMETER A LAS MISMAS A LA LUZ EN PRESENCIA DE UN TETRAPIROLE ACTIVADO POR LA LUZ, EN EL QUE EL MEJORAMIENTO COMPRENDE EL TRATAMIENTO DE DICHAS CELULAS CON UN COMPUESTO QUE INHIBE LA CONVERSION ENZIMATICA DEL PROTOPORFIRINOGENO EN PROTOPORFIRINA IX AL OXIDAR DICHO PROTOPORFIRINOGENO EN DICHAS CELULAS QUE CAUSAN UNA CONSTRUCCION DE PROTORPORFIRINA IX EN DICHAS CELULAS. TAMBIEN SE EXPONE UN METODO PARA LA PRODUCCION DE PROTOPORFIRINA IX QUE COMPRENDE EL CRECIMIENTO DE LA MICROALGA EUKARIOTICA EN LA PRESENCIA DE UN INHIBIDOR OXIDADO DE PROTOPORFIRINOGENO.
ES90901350T 1988-12-12 1989-12-08 Inhibidores de protorfirinogeno y su uso en composiciones para detectar y tratar tumores. Expired - Lifetime ES2051675T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28515188A 1988-12-12 1988-12-12
US33500789A 1989-04-07 1989-04-07
US35133189A 1989-05-03 1989-05-03

Publications (2)

Publication Number Publication Date
ES2051675T1 true ES2051675T1 (es) 1994-07-01
ES2051675T3 ES2051675T3 (es) 1994-11-01

Family

ID=27403508

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90901350T Expired - Lifetime ES2051675T3 (es) 1988-12-12 1989-12-08 Inhibidores de protorfirinogeno y su uso en composiciones para detectar y tratar tumores.

Country Status (28)

Country Link
EP (1) EP0447491B1 (es)
JP (1) JP2545000B2 (es)
KR (1) KR930003116B1 (es)
AR (1) AR243605A1 (es)
AT (1) AT400520B (es)
AU (1) AU633537B2 (es)
BR (1) BR8907817A (es)
CA (1) CA2004979A1 (es)
CH (1) CH681779A5 (es)
DE (2) DE3991484T (es)
DK (1) DK110791A (es)
EG (1) EG18822A (es)
ES (1) ES2051675T3 (es)
FI (1) FI912784A0 (es)
GB (1) GB2247404B (es)
GR (1) GR1000609B (es)
HU (1) HUT58202A (es)
IE (1) IE62621B1 (es)
IL (1) IL92622A (es)
LU (1) LU87949A1 (es)
LV (1) LV10303B (es)
MC (1) MC2171A1 (es)
NO (1) NO912228L (es)
NZ (1) NZ231658A (es)
OA (1) OA09362A (es)
PT (1) PT92546B (es)
SE (1) SE505938C2 (es)
WO (1) WO1990006748A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298502A (en) * 1988-12-12 1994-03-29 Fmc Corporation Method and composition for photodynamic treatment and detection of tumors
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US6084155A (en) 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
HUP9900623A3 (en) * 1996-02-28 2001-11-28 Novartis Ag Promoters from plant protoporphyrinogen oxidase genes
JPH10330359A (ja) * 1997-03-31 1998-12-15 Nippon Bayeragrochem Kk フエニルアセチレン誘導体及び除草剤
DE102005017152B4 (de) * 2005-04-13 2007-02-08 Lindauer Dornier Gmbh Verfahren zum Trocknen von vorzugsweise plattenförmigen Produkten und Durchlauftrockner in Mehretagenbauweise
SI2443102T1 (sl) 2009-06-19 2013-08-30 Basf Se Herbicidni benzoksazinoni
US8445407B2 (en) * 2009-11-02 2013-05-21 Basf Se Herbicidal tetrahydrophthalimides
CN103221409B (zh) * 2010-10-01 2016-03-09 巴斯夫欧洲公司 除草的苯并*嗪酮类
US8916501B2 (en) 2010-12-15 2014-12-23 Basf Se Herbicidal compositions
CN102875569A (zh) * 2012-09-27 2013-01-16 南开大学 具有除草活性和抗肝癌活性的异噁唑并嘧啶酮(或三嗪酮)类化合物
AU2017375394B2 (en) * 2016-12-16 2021-10-21 Basf Se Herbicidal phenyltriazolinones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
US4404019A (en) * 1980-12-24 1983-09-13 Sumitomo Chemical Company, Limited 3-Chloro-1-phenyl-1,2,4-triazolin-5-ones and their use as herbicides
CH651029A5 (de) * 1980-12-25 1985-08-30 Nihon Nohyaku Co Ltd Triazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende herbizide mittel.
JPS60190711A (ja) * 1984-03-09 1985-09-28 Tokyo Tanabe Co Ltd プロトポルフイリン類注射用製剤
US4755217A (en) * 1987-01-15 1988-07-05 Fmc Corporation Triazinedione herbicides
US4761174A (en) * 1987-04-14 1988-08-02 Fmc Corporation Triazolin-5-one herbicides

Also Published As

Publication number Publication date
LU87949A1 (fr) 1991-12-16
LV10303B (en) 1995-08-20
LV10303A (lv) 1994-10-20
KR930003116B1 (ko) 1993-04-19
PT92546B (pt) 1995-09-12
CH681779A5 (es) 1993-05-28
SE9101807D0 (sv) 1991-06-12
EP0447491B1 (en) 1993-08-11
DK110791D0 (da) 1991-06-11
SE505938C2 (sv) 1997-10-27
AR243605A1 (es) 1993-08-31
EG18822A (en) 1994-09-29
AU633537B2 (en) 1993-02-04
CA2004979A1 (en) 1990-06-12
JP2545000B2 (ja) 1996-10-16
JPH04501420A (ja) 1992-03-12
HUT58202A (en) 1992-02-28
WO1990006748A2 (en) 1990-06-28
EP0447491A1 (en) 1991-09-25
DE3991484C2 (de) 1995-02-23
GR890100817A (en) 1991-03-15
KR910700046A (ko) 1991-03-13
NO912228D0 (no) 1991-06-11
MC2171A1 (fr) 1992-05-22
AU4822290A (en) 1990-07-10
IL92622A (en) 1996-05-14
BR8907817A (pt) 1991-10-22
IE893925L (en) 1990-06-12
NO912228L (no) 1991-06-11
FI912784A7 (fi) 1991-06-10
DK110791A (da) 1991-08-12
GB2247404B (en) 1993-03-03
OA09362A (en) 1992-09-15
WO1990006748A3 (en) 1990-10-04
DE3991484T (es) 1991-11-21
ATA903489A (de) 1995-06-15
GB2247404A (en) 1992-03-04
AT400520B (de) 1996-01-25
GB9110472D0 (en) 1991-11-27
IE62621B1 (en) 1995-02-22
FI912784A0 (fi) 1991-06-10
PT92546A (pt) 1990-06-29
NZ231658A (en) 1992-05-26
GR1000609B (el) 1992-08-31
SE9101807L (sv) 1991-06-12
IL92622A0 (en) 1990-08-31
ES2051675T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
ES2051675T3 (es) Inhibidores de protorfirinogeno y su uso en composiciones para detectar y tratar tumores.
ES2007341A6 (es) Un procedimiento para producir m-csf
ES8705764A1 (es) Procedimiento fotodinamico de inactivacion de virus
ES2192201T3 (es) Compuestos de piranona utiles para el tratamiento de infecciones retrovirales.
MX9700237A (es) Combinaciones inhibidoras de proteasa retroviral.
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
ES2131116T3 (es) Analogos de nucleotidos enantiomericos antirretrovirales.
ES2055197T3 (es) Una composicion que contiene d-cicloserina y d-alanina para el aumento de la memoria y el aprendizaje o el tratamiento de un trastorno cognitivo o psicotico.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
ES2189782T3 (es) Derivados de pteridina opticamente activos.
ES2043786T3 (es) Un proceso para la preparacion de un pentasacarido.
NO944997D0 (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
ES2059575T3 (es) Aductos modificados de poliepoxido y polioxialquilen-poliamidas.
ES8402290A1 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
ES8103162A1 (es) Un procedimiento para la preparacion de interferon tipo ii.
ES2063013T3 (es) Procedimiento para eliminar pirogenos.
ES2177642T3 (es) Uso de ciertos derivados de acido metanobisfosfonico para prevenir el desprendimiento y la migracion de protesis.
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
MX9303127A (es) Metodo para reducir selectivamente la poblacion celular de leucocitos.
ES2138603T3 (es) Procedimiento para el aislamiento de los factores ix, x y ii altamente purificados a partir del complejo protrombinico o del plasma humano.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2091249T3 (es) Analogos de iludina utilizables como agentes antitumorales.
ES2047033T3 (es) Un metodo para preparar compuestos de hidroxivitamina d.
ES2185655T3 (es) Fracciones de acido aurintricarboxilico y analogos con actividad anti-angiogenica y metodos de uso.
ES8406461A1 (es) Procedimiento para la obtencion de benzofuranonas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 447491

Country of ref document: ES